1 suspended. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Suspended 1 |
Follow PANDA-VAC: new trials by email Literature Review of PANDA-VAC trials Research Report on PANDA-VAC
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of a Personalized and Adaptive Neoantigen Dose-Adjusted Vaccine Concurrently With Pembrolizumab PANDA-VAC, Pembrolizumab - Squamous Cell Lung Cancer, Squamous Non-small Cell Lung Cancer | Phase 1 | Suspended | UNC Lineberger Comprehensive Cancer Center | 6 | 2027-05-20 | 2026-04-23 |
Head and Neck Neoplasms (1) · Lung Neoplasms (1) · Squamous Cell Carcinoma of Head and Neck (1)
UNC Lineberger Comprehensive Cancer Center (1)
United States (1)
Jared Weiss, MD (1)